Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

4.74%

Threshold

Crossed upwards

Timeline

Published

26.01.2021

Transaction

20.01.2021

Voting rights breakdown

Voting rights acquired4.74%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBL1M00050

Beneficial owner

Frank-Jan van der Velden

Declared address

Frank-Jan van der Velden, Echteld

Incubation B.V., holding 1'112'101 shares (3.39% of the Company's voting rights), is controlled on a 50:50 basis by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Mr. Frank-Jan van der Velden, Echteld, The Netherlands and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Mr. Clemens von Bitterswijk, Ruigahuizen, The Netherlands. Mr. Frank-Jan van der Velden, Echteld, directly holds 83'144 options (0,25% of the Company's voting rights). Mr. Clemens von Bitterswijk, Ruigahuizen, The Netherlands, directly hold 12'125 options (0,04% of the Company's voting rights).

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open